Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

First-in-class mitotic kinase inhibitor shows anticancer properties

Dec. 19, 2011

Results presented from pilot study of Panvac vaccine

Dec. 19, 2011

Wilex discusses development of Redectane with FDA

Dec. 16, 2011

Kyowa Hakko Kirin presents novel kynurenine production inhibitors

Dec. 16, 2011

Onyx Pharmaceuticals joins MMRF's personalized medicine initiative

Dec. 16, 2011

Phase II data encourage further development of aminopeptidase N inhibitor in leukemia

Dec. 16, 2011

GSK files for Japanese approval of oral kinase inhibitor in malignant soft tissue sarcoma

Dec. 16, 2011

Threshold reports encouraging results from ongoing TH-302 trial in advanced leukemias

Dec. 16, 2011

PARP inhibitor shows promise combined with temozolomide in advanced solid tumors

Dec. 16, 2011

PANORAMA 1 study evaluates panobinostat in multiple myeloma

Dec. 16, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...